Professor of Pharmacology - Molecular Pharmacology

Full CV

Education

• Degree: BScinPharmacy, UniversityofPatras, (1985-1989) 
• Doctorate: PhD in Pharmacology, Medical College of Georgia, GA, USA (1990-1994) 
• Post doctoral training: Vascular Biology Center, Medical College of Georgia, USA; (1994-1995)
• Boyer Center for Molecular Medicine, Yale University School of Medicine; 1995-1998

Teaching

• Undergraduate courses/labs: Pharmacology I, Pharmacology II, Molecular Pharmacology 
• Graduate courses: Biochemical and molecular Pharmacology, Advanced Pharmacology, Molecular Pharmacology-oxidative stress

Research topics

• Preclinical drug screening 
• Molecular Pharmacology
• Cardiovascular Pharmacology 
• Cellsignalingandvascularbiology 
• Gasotransmitters (ΝΟ και H2S)

Distinctions

• PhD in Pharmacology with Distinction, Medical College of Georgia
• Fellow of the American Heart Association
• Fellow of the British Pharmacological Society
• Most influential Greek Scientist list (by Prof. Ioannidis, ISBN 978-960-04-4489-6)
• Top 1% of scientists in all fields based on citations doi: 10.1371/journal.pbio.3000384.
• Visiting Professor UMDNJ, UTMB, LSU, Maastricht University and McGill University 
• British Journal of Pharmacology, Editorial board member (2009-2018)
• Arteriosclerosis, Thrombosis and Vascular Biology, Editorial board member  (2010-present)
• Journal of Pharmacology & Experimental Therapeutics, Editorial board member member  (2012-present)
• European Network of Gasotrnsmitters, Chair
• Secretary General, European Federation of Pharmacological Societies, 2016-2020
• European Medicines Agency, Pediatric Committee National Delegate

Recent publications

• SIBibli, JHu, FSigala, IWittig, JHeidler, SZukunft, DTsilimigras, VRandriamboavonjy, JWittig, BKojonazarov, CSchürmann, MSiragusa, DSiuda, BLuck, RAbdelMalik, KFilis, GZografos, CChen, DWang, JPfeilschifter, RBrandes, CSzabo, APapapetropoulos, IFleming. Cystathionine-γ lyase sulfhydrates the RNA binding protein HuR to preserve endothelial cell function and delay atherogenesis. Circulation 39:101-114, 2019
• SI Bibli, Z Zhou, S Zukunft, B Fisslthaler,  I Andreadou, C Szabo, P Brouckaert, I Fleming, A Papapetropoulos. Tyrosine phosphorylation of eNOS regulates myocardial survival after an ischemic insult: role of PYK2 Cardiovasc Res. 113:926-937, 2017.
• SI Bibli, C Szabo, A Chatzianastasiou, B Luck, S Zukunft, I Fleming, A Papapetropoulos. Hydrogen sulfide preserves eNOS function by inhibiting PYK2: implications for cardiomyocyte survival and cardioprotection. Mol. Pharm. 92:718-730, 2017.
• M von Wantoch Rekowski, V Kumar, Z Zhou, J Moschner, A Marazioti, M Bantzi, GA Spyroulias, F van den Akker, A Giannis, A Papapetropoulos. Insights into soluble guanylyl cyclase activation derived from improved heme-mimetics. J. Med. Chem. 56, 8948-52, 2013
• C Szabo, C Coletta, C Chao, K Módis., B Szczesny, A Papapetropoulos, MR Hellmich. Tumor-derived H2S, produced by cystathionine-β-synthase, stimulates bioenergetics, cell proliferation and angiogenesis in colon cancer. Proc Natl Acad Sci USA 110:12474-9, 2013

Contact

Andreas Papapetropoulos, B.Pharm, Ph.D., F.A.H.A., FBPharmacolS
Professor of Pharmacology
Faculty of Pharmacy
Department of Pharmaceutical Chemistry
University of Athens
University Campus, Zografou
Athens 15771 Greece
Tel (+30)210-7274786
Fax: (+30) 210 727-4747
E-mail: apapapet@pharm.uoa.gr